Home > Past meetings > 3rd Meeting 2018 > Programme > Working Group – Clinical

Working Group – Clinical

Date: Monday 24 September 2018
Time: 09:00 – 12:30

Time Session
09:00 – 10:30 Clinical Abstracts
(8 mins for presentation + 2 mins for questions)
Chairs: Laura Renkonen-Sinisalo (Finland), Ingrid Winship (Australia)
09:00 – 09:10 N35: An assessment of endometrial cancer risk markers in lynch syndrome patients – Angel Alonso Sanchez (Spain)
09:10 – 09:20 N81:Genomic and transcriptomic profiling of duodenal adenomas in familial adenomatous (FAP) and MUTYH-associated polyposis (MAP) – Elena Meuser (UK)
09:20 – 09:30 The phenotype of POLE and POLD1 – Ingrid Winship (Australia)
09:30 – 09:40 N87:SELINA – clinical trial on lowering the risk of malignancies by optimizing selenium levels in females from families with hereditary breast cancer – Jan Lubinski (Poland)
09:40 – 09:50 N38:Yield of Lynch syndrome surveillance for individual MMR genes – Anja Wagner (The Netherlands)
09:50 – 10:00 N43:Hide and seek with hereditary cancer: testing the effectiveness and cost-effectiveness of implementation approaches for translating Lynch Syndrome evidence into practice – Natalie Taylor (Australia)
10:00 – 10:10 N83:Surveillance recommendations for first-degree relatives of patients with unexplained multiple colorectal adenomas: a nationwide survey of UK regional genetic services -Bianca Desouza (UK)
10:10 – 10:20 N58:The cost of identifying Lynch syndrome carriers in Australia – Mary Dillon (Finland)
10:20 – 10:30 N11:A dominantly inherited 5’UTR variant causing methylation associated silencing of BRCA1 as a novel cause of breast and ovarian cancer – Gareth D. Evans (UK)
10:30 – 11:00 Coffee break
Chairs: Gareth D. Evans (UK), Zohar Levi (Israel)
11:00 – 11:20 N27:The management of gynaecological cancers in Lynch syndrome: the Manchester International Consensus Meeting – Emma Crosbie (UK)
11:20 – 11:40 N42: Improving triaging of patients with sebaceous neoplasiaa for the identification of Muir-Torre/Lynch syndrome – Ingrid Winship (Australia)
11:40 – 12:00 N67:Penetrance for carriers of a DNA mismatch repair gene specific variant – Aung Ko Win (Australia)
12:00 – 12:30 Hi-speed abstract presentations
(3 mins for presentation + 2 mins for questions)
12:00 – 12:05 N47:Prevalence of mismatch repair deficiency in small bowel carcinomas and neuroendocrine tumours – Manon Suerink (The Netherlands)
12:05 – 12:10 N84:Mutations in MutYH gene among Russian patients with colorectal polyps – Alex Tsukanov (Russian Federation)
12:10 – 12:15 N63:Clinical and molecular characterization of Lynch-like syndrome -Maria Dolores Picó (Spain)
12:15 – 12:20 N61:Physical activity and the risk of colorectal cancer in Lynch syndrome – S Ghazaleh Dashti (Australia)
12:20 – 12:25 N68:A multidisciplinary approach to familial pancreatic cancer enriches the proportion of patients with pancreatic cancer susceptibility -Giulia Martina Cavestro (Italy)
12:25 – 12:30 N05:Exogenous and endogenous associated factors to early onset colorectal cancer -Raffaella Alessia Zuppardo (Italy)
Top